aloxistatin has been researched along with Brain Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahill, J; Solaroglu, I; Tsubokawa, T; Yata, K; Yatsushige, H; Zhang, JH | 1 |
| Calvert, JW; Shimamura, N; Solaroglu, I; Tsubokawa, T; Yamaguchi-Okada, M; Yata, K; Zhang, JH | 1 |
2 other study(ies) available for aloxistatin and Brain Edema
| Article | Year |
|---|---|
Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Calpain; Cathepsin B; Cerebral Hemorrhage; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Induction; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Infarction, Middle Cerebral Artery; Leucine; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nerve Tissue Proteins; Neuroprotective Agents; Premedication; Rats; Rats, Sprague-Dawley; Reperfusion; Single-Blind Method | 2006 |
Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats.
Topics: Analysis of Variance; Animals; Apoptosis; Brain Edema; Brain Infarction; Brain Ischemia; Calpain; Caspase 3; Caspases; Cathepsins; Endothelium, Vascular; Functional Laterality; Gene Expression; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Leucine; Male; Neurologic Examination; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Tetrazolium Salts | 2006 |